These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 4085644)
21. Isonicotinates, nicotinates and clofibrates of N-methyl-N-(2-hydroxyethyl or 3-hydroxypropyl)--1,3,3-trimethylbicyclo [2.2.1]heptan-2-endo-amine with hypocholesterolemic and hypolipidemic activity. Bondavalli F; Bruno O; Schenone P; Vacca C; De Carlo R; Marmo E Farmaco Sci; 1987 Apr; 42(4):251-7. PubMed ID: 3595837 [TBL] [Abstract][Full Text] [Related]
22. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents. Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antihyperlipidemic activity of some novel condensed 2-chloroalkyl-4-chloro/hydroxy-5,6-disubstituted pyrimidines. Kathiravan MK; Shishoo CJ; Kumar KG; Roy SK; Mahadik KR; Kadam SS; Jain KS Arzneimittelforschung; 2007; 57(9):599-606. PubMed ID: 17966759 [TBL] [Abstract][Full Text] [Related]
24. Hypolipidemic effect of a new aryloxy compound, S-8527, in experimental animals. Suzuki K; Aono S; Nakatani H Jpn J Pharmacol; 1974 Jun; 24(3):407-14. PubMed ID: 4449146 [No Abstract] [Full Text] [Related]
25. New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action. Ladopoulou E; Matralis AN; Kourounakis AP J Med Chem; 2013 Apr; 56(8):3330-8. PubMed ID: 23581491 [TBL] [Abstract][Full Text] [Related]
26. Studies on hypolipidemic agents. II. Synthesis and pharmacological properties of alkylpyrazole derivatives. Seki K; Isegawa J; Fukuda M; Ohki M Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1568-77. PubMed ID: 6467462 [No Abstract] [Full Text] [Related]
27. Design, synthesis and biological evaluation of some 2-azetidinone derivatives as potential antihyperlipidemic agents. Arya N; Dwivedi J; Khedkar VM; Coutinho EC; Jain KS Arch Pharm (Weinheim); 2013 Dec; 346(12):872-81. PubMed ID: 24142910 [TBL] [Abstract][Full Text] [Related]
28. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate. Yokoyama S; Yamamoto A; Kurasawa T Atherosclerosis; 1988 Mar; 70(1-2):179-81. PubMed ID: 3355613 [No Abstract] [Full Text] [Related]
29. Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation. Sheikha GA; Bkhaitan MM; Kalloush H; Hamadneh L; Khalaf RA; Al-Qirim T; Al-Hiari Y Chem Pharm Bull (Tokyo); 2018; 66(4):423-426. PubMed ID: 29607907 [TBL] [Abstract][Full Text] [Related]
30. [Hypolipidemic activity of substances structurally close to penphenone in rats and mice]. Polikarpova LI; Reznik SE; Ryzhenkov VV; Khechinashvili GG; Petrova LA Vopr Med Khim; 1978; 24(6):835-9. PubMed ID: 216145 [TBL] [Abstract][Full Text] [Related]
31. On the hypolipemic properties of bendaline. Marmo E; Lampa E; Matera MG; Spadaro R; Romano AR; Guarino V J Med; 1984; 15(2):105-25. PubMed ID: 6595341 [TBL] [Abstract][Full Text] [Related]
32. [Probucol in the treatment of hyperlipidemias]. Feder D; Langer AL; Alexandrino E; Medeiros S; Lotto M; Valente O Arq Bras Cardiol; 1986 Feb; 46(2):77-80. PubMed ID: 3827649 [No Abstract] [Full Text] [Related]